Sekar Kathiresan
2021
In 2021, Sekar Kathiresan earned a total compensation of $5.6M as Chief Executive Officer at Verve Therapeutics, a 131% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $455,400 |
---|---|
Option Awards | $4,585,975 |
Salary | $519,000 |
Other | $12,183 |
Total | $5,572,558 |
Kathiresan received $4.6M in option awards, accounting for 82% of the total pay in 2021.
Kathiresan also received $455.4K in non-equity incentive plan, $519K in salary and $12.2K in other compensation.
Rankings
In 2021, Sekar Kathiresan's compensation ranked 2,293rd out of 12,415 executives tracked by ExecPay. In other words, Kathiresan earned more than 81.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,293 | 82nd |
Manufacturing | 895 | 84th |
Chemicals And Allied Products | 343 | 86th |
Drugs | 297 | 86th |
Pharmaceutical Preparations | 191 | 88th |
Kathiresan's colleagues
We found two more compensation records of executives who worked with Sekar Kathiresan at Verve Therapeutics in 2021.